Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL700321 | 0.83 | MAPK1 (0.31) | MAPK1ALDH1A1LMNATP53MAPT | |
| SCHEMBL700460 | 0.79 | MAPK1 (0.33) | MAPK1 | |
| SCHEMBL2319771 | 0.79 | ALDH1A1 (0.35) | MAPK1ALDH1A1LMNATP53MAPT | |
| Tert-Butylamine SCHEMBL427070 | 0.79 | ALDH1A1 (0.35) | MAPK1ALDH1A1LMNATP53MAPT | |
| SCHEMBL4321722 | 0.79 | TAAR1 (0.37) | MAPK1ALDH1A1LMNATP53MAPT | |
| SCHEMBL5089460 | 0.78 | ALDH1A1 (0.39) | MAPK1ALDH1A1LMNATP53MAPT | |
| SCHEMBL701205 | 0.78 | TSHR (0.39) | ALDH1A1 | |
| SCHEMBL701320 | 0.78 | ALDH1A1 (0.33) | ALDH1A1LMNATP53NPSR1TAAR1 | |
| Benzene SCHEMBL31091106 | 0.78 | ALDH1A1 (0.50) | MAPK1ALDH1A1LMNATP53MAPT | |
| SCHEMBL11707018 | 0.78 | ALDH1A1 (0.50) | MAPK1ALDH1A1LMNATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260098122-A1 | HEAT-CURABLE RESIN COMPOSITION AND USES THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-04-09 | — | — | US | disclosed |
| EP-4700060-A1 | HEAT-CURABLE RESIN COMPOSITION AND USES THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-02-25 | — | — | EP | disclosed |
| EP-4682185-A1 | THERMOSETTING BISCITRACONIMIDE RESIN COMPOSITION | Shin-Etsu Chemical Co., Ltd. (JP) | 2026-01-21 | — | — | EP | disclosed |
| US-20260015462-A1 | THERMOSETTING BISCITRACONIMIDE RESIN COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2026-01-15 | — | — | US | disclosed |
| EP-4678694-A1 | RESIN COMPOSITION AND METHOD FOR PRODUCING SAME, AND RESIN SHEET | Ajinomoto Co., Inc. (JP) | 2026-01-14 | — | — | EP | disclosed |
| US-20250388747-A1 | EPOXY RESIN COMPOSITION | SHINETSU CHEMICAL CO (JP) | 2025-12-25 | — | — | US | disclosed |
| EP-4669069-A1 | ELECTRONIC DEVICE | AJINOMOTO CO., INC. (JP) | 2025-12-24 | — | — | EP | disclosed |
| EP-4667522-A1 | EPOXY RESIN COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20250382409-A1 | THERMOSETTING RESIN COMPOSITION AND USE THEREOF | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-12-18 | — | — | US | disclosed |
| US-20250382505-A1 | RESIN COMPOSITION AND METHOD FOR PRODUCING SAME, AND RESIN SHEET | AJINOMOTO CO., INC. (JP) | 2025-12-18 | — | — | US | disclosed |
| EP-2616460-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE. | Otsuka Pharmaceutical Co., Ltd. (JP) | 2013-07-24 | — | — | EP | disclosed |
| WO-2013015456-A1 | METHOD FOR PRODUCING BENZO[B]THIOPHENE COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-01-31 | — | — | WO | disclosed |
| WO-2012036253-A1 | HETEROCYCLIC COMPOUNDS FOR TREATING OR PREVENTING DISORDERS CAUSED BY REDUCED NEUROTRANSMISSION OF SEROTONIN, NOREPHNEPHRINE OR DOPAMINE. | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2012-03-22 | — | — | WO | disclosed |
| US-8124809-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2012-02-28 | — | — | US | disclosed |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-09-29 | — | — | US | disclosed |
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2011-07-07 | — | — | US | disclosed |
| US-7728176-B2 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-06-01 | — | — | US | disclosed |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| US-20070098616-A1 | Process for producing phosponium borate compound, novel phosphonium borate compound, and method of using the same | HOKKO CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-05-03 | — | — | US | disclosed |
| EP-1688424-A1 | PROCESS FOR PRODUCING PHOSPHONIUM BORATE COMPOUND, NOVEL PHOSPHONIUM BORATE COMPOUND, AND METHOD OF USING THE SAME | HOKKO CHEMICAL INDUSTRY CO. LTD. (JP) | 2006-08-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388747-A1 | EPOXY RESIN COMPOSITION | EED, ELL, EPCAM | MAPK1 2928/4885ALDH1A1 61/4885LMNA 2202/4885 |
| US-20260098122-A1 | HEAT-CURABLE RESIN COMPOSITION AND USES THEREOF | SEM1, EEF1A1, HEATR1 | MAPK1 2379/4885ALDH1A1 706/4885LMNA 2938/4885 |
| US-20110166389-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | CA4, EPB41, MAPK4 | MAPK1 218/4885ALDH1A1 4654/4885LMNA 4579/4885 |
| US-20110237799-A1 | Process for Producing Phosphonium Borate Compound, Novel Phosphonium Borate Compound, and Method of Using the Same | EPB41, CA4, RBBP4 | MAPK1 278/4885ALDH1A1 4626/4885LMNA 4520/4885 |
| US-20260015462-A1 | THERMOSETTING BISCITRACONIMIDE RESIN COMPOSITION | GABRE, MECP2, FHIT | MAPK1 492/4885ALDH1A1 2841/4885LMNA 1133/4885 |
| US-20090305877-A1 | Process for producing phosphonium borate compound, novel phosphonium borate compound, and method of using the same | PHOSPHO1, BRI3BP, CA4 | MAPK1 350/4885ALDH1A1 3637/4885LMNA 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.